Cargando…
Managing risks in drug discovery: reproducibility of published findings
In spite of tremendous advances in biopharmaceutical science and technology, the productivity of pharmaceutical research and development has been steadily declining over the last decades. The reasons for this decline are manifold and range from improved standard of care that is more and more difficu...
Autores principales: | Kannt, Aimo, Wieland, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785199/ https://www.ncbi.nlm.nih.gov/pubmed/26883784 http://dx.doi.org/10.1007/s00210-016-1216-8 |
Ejemplares similares
-
Towards reproducible computational drug discovery
por: Schaduangrat, Nalini, et al.
Publicado: (2020) -
Publishing Open, Reproducible Research With Undergraduates
por: Strand, Julia F., et al.
Publicado: (2019) -
Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds
por: Kannt, Aimo, et al.
Publicado: (2012) -
Publishing computational research - a review of infrastructures for reproducible and transparent scholarly communication
por: Konkol, Markus, et al.
Publicado: (2020) -
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
por: Mishra, Aniket, et al.
Publicado: (2022)